News | Proton Therapy | January 28, 2019

First patient at Apollo Proton Cancer Centre in Chennai, India, treated for prostate cancer

Southern Asia's First Proton Therapy Center Begins Treatments

January 28, 2019 — IBA (Ion Beam Applications SA) announced the opening of the Apollo Proton Cancer Centre in Chennai, India, and the first treatment of a patient with proton therapy in Southern Asia.

The medical team from the Apollo Proton Cancer Centre in Chennai successfully treated the patient with the IBA Proteus Plus multi-room proton therapy solution on Jan. 2, 2019. The patient was treated for prostate cancer and proton therapy was used to maximize preservation of the surrounding healthy tissues.

Proton therapy has already benefited to more than 180,000 patients treated worldwide. This number is expected to double over the next five years, supported by expert opinion and clinical experience. In recent years, this has led centers in Japan, Korea, the Netherlands, Germany and the U.S. to increase the number of indications treated with proton therapy.

Proton therapy offers many potential benefits to the patients, such as:

  • The potential increase in therapeutic dose within the tumor to raise the probability of eradicating it;
  • The possibility of preserving healthy tissues around the tumor with a consequent reduction in side effects; and
  • A reduction in the overall dose delivered to the patient, thus reducing the risk of a second cancer.

For more information: www.iba-worldwide.com


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
Subscribe Now